Your browser doesn't support javascript.
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
Isitt, Catherine; Sjöholm, Daniel; Hergens, Maria-Pia; Granath, Fredrik; Nauclér, Pontus.
  • Isitt C; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden. Electronic address: catherine.isitt@regionstockholm.se.
  • Sjöholm D; Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Sweden.
  • Hergens MP; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden; Department of Communicable Disease Control and Prevention, Stockholm County Council, Stockholm, Sweden.
  • Granath F; Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Sweden.
  • Nauclér P; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden. Electronic address: pontus.naucler@regionstockholm.se.
Vaccine ; 40(20): 2823-2827, 2022 05 03.
Article in English | MEDLINE | ID: covidwho-1764023
ABSTRACT
Vaccination against SARS-CoV-2 started in Region Stockholm, Sweden in December 2020 with those in long-term care facilities or receiving home care vaccinated first followed by those aged over 80 years. In this population-based, retrospective cohort study, we performed a Poisson regression to model the expected incidence of infections and deaths which we compared to the observed incidence and compared this to an unvaccinated control group of those aged 18-79 years. The aim of this study was to measure the early impact of the vaccination programme in Region Stockholm. Infections and deaths reduced substantially amongst the first two groups targeted for SARS-CoV-2 vaccination with an estimated total 3112 infections prevented, and 854 deaths prevented in these two groups from 4 weeks after the introduction of vaccination through to 2nd May 2021.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article